Clinical Trial Update: Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pharmacokinetics, safety, and tolerability of Alpha-1 MP versus Prolastin in adults with Alpha-1 antitrypsin deficiency; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• Alpha-1 MP
• Prolastin (alpha-1 proteinase inhibitor (human))

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2014-09-09